JLE

Epileptic Disorders

MENU

Dyskinesia as a new adverse effect of hormonal treatment in West syndrome Volume 16, issue 1, March 2014

  • [Azam et al., 2005] Azam M., Bhatti N., Krishin J. Use of ACTH and prednisolone in infantile spasms: experience from a developing country. Seizure. 2005;14:552-556.
  • [Baram, 1993] Baram T.Z. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurology. 1993;33:231-236.
  • [Baram et al., 1996] Baram T.Z., Mitchell W.G., Tournay A. High-dose corticotropin (acth) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. 1996;97:375-379.
  • [Berg et al., 2010] Berg A.T., Berkovic S.F., Brodie M.J. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51:676-685.
  • [Bishop et al., 2012] Bishop C., George J.A., Buchta W. Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats. Eur J Neurosci. 2012;36:2839-2848.
  • [Blumkin et al., 2012] Blumkin L., Suls A., Deconinck T. Neonatal seizures associated with a severe neonatal myoclonus like dyskinesia due to a familial gene mutation. Eur J Paediatr Neurol. 2012;16:356-360. KCNQ2
  • [Chiron et al., 1997] Chiron C., Dumas C., Jambaquè I., Mumford J., Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997;26:389-395.
  • [Dill et al., 2013] Dill P., Datta A.N., Weber P., Schneider J. Are vigabatrin-induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?. Eur J Paediatr Neurol. 2013;17:311-315.
  • [Epstein, 2007] Epstein D. Orofacial automatisms induced by acute withdrawal from high-dose midazolam mimicking nonconvulsive status epilepticus in a child. Mov Disord. 2007;22:712-715.
  • [Fong et al., 2013] Fong C.Y., Osborne J.P., Edwards S.W. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev Med Child Neurol. 2013;55:862-867.
  • [Gherpelli, 1998] Gherpelli J.L. Choreoathetosis after cardiac surgery with hypothermia and extracorporeal circulation. Pediatr Neurol. 1998;19:113-118.
  • [Haga et al., 1992] Haga Y., Watanabe K., Negoro T. Optimal ACTH dosage for treating West syndrome. Jpn J Psychiatry Neurol. 1992;46:432-434.
  • [Holtbernd and Eidelberg, 2012] Holtbernd F., Eidelberg D. Functional brain networks in movement disorders: recent advances. Curr Opin Neurol. 2012;25:392-401.
  • [Hrachovy et al., 1994] Hrachovy R.A., Frost J.D. Jr., Glaze D.G. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr. 1994;124:803-806.
  • [Kitamura et al., 2002] Kitamura K., Yanazawa M., Sugiyama N. Mutation of causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet. 2002;32:359-369. ARX
  • [Kleinig, 2008] Kleinig T.J. The distinctive movement disorder in ovarian teratoma-associated encephalitis. Mov Disord. 2008;23:1256-1261.
  • [Paciorkowski et al., 2011] Paciorkowski A.R., Thio L.L., Dobynss W.B. A genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355-367.
  • [Stromme et al., 2002] Stromme P., Mangelsdorf M.E., Scheffer I.E., Gecz J. Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX. Brain Dev. 2002;24:266-268.
  • [Yilmaz et al., 2013] Yilmaz A.E., Donmez A., Orun E. Methylphenidate-induced acute orofacial and extremity dyskinesia. J Child Neurol. 2013;28:781-783.
  • [Zanus, 2012] Zanus C. Involuntary movements after correction of vitamin B12 deficiency: a video-case report. Epileptic Disord. 2012;14:174-180. 10.1684/epd.2012.0507